Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-15

FDA Approved: CAPECITABINE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s supplemental application for Capecitabine, updating regulatory status for this cancer drug. The action likely involves labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)